Nasdaq · Biotech stocks database
TWST (Twist Bioscience Corporation) stock: $120.79, $8.01B market cap, $166.8M cash, $7.84B EV, $8.30B fully diluted market cap. Data from Fully Diluted's biotech stocks database.
We believe Twist Bioscience is uniquely positioned to help accelerate their efforts and the faster our customers succeed, the better for all of us. We have developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.
Source: 10-K FY2025 via SEC EDGAR
| Cash | $166.8M |
|---|---|
| Debt | $0.0M |
| Net cash | $166.8M |
| Enterprise value | $7,841.7M |
| Basic shares | 62.7M shares |
| Fully diluted shares | 68.7M shares |
| Fully diluted market cap | $8,298.7M |
| Cash per share | $2.66 |
| Quarterly burn | +$1.1M generated |
Cash figures as of 2026-06-30. Database snapshot: 2026-11-07.
Cap table as of 2026-07-29.
Loading TWST daily closes…